Supply Status for Epipen

Supply Status for Epipen

June 21, 2019

Mylan’s manufacturing partner Meridian Medical Technologies, a subsidiary of Pfizer that manufactures EpiPen, has experienced recent manufacturing challenges which resulted in interruptions in the production of EpiPen 0.3mg and EpiPen Jr 0.15mg Adrenaline Auto-Injectors (AAIs).

 

To help manage product availability on an ongoing basis until a steady supply resumes, Mylan has assigned a prescription-only process for EpiPen 0.3mg, meaning patients can obtain up to a maximum of two EpiPen 0.3mg AAIs per prescription.

 

The prescription-only process does not affect EpiPen Jr 0.15mg.

 

Further details for patients, prescribers, pharmacists and schools can be found on the Epipen website.




More Latest News >

FMD Alert: Class 2 (EL (19)A/19)

Please see an FMD Class 2 Alert below https://www.gov.uk/drug-device-alerts/fmd-alert-class-2-el-19-a-19?utm_source=5e25416e-83ec-44ee-bc88-15154ad6357e&utm_medium=email&utm_campaign=govuk-notifications&utm_content=immediate&dm_i=EQ,6EGN0,JNZO7,PCKB8,1

Supply Status for Epipen

Mylan’s manufacturing partner Meridian Medical Technologies, a subsidiary of Pfizer that manufactures EpiPen, has experienced recent manufacturing challenges which resulted...

Epanutin (phenytoin) 30mg/5ml oral suspension supply disruption

Please find an article below about a current shortage of Epanutin (phenytoin) 30mg/5ml oral suspension supply disruption https://www.rpharms.com/publications/pharmacy-alerts/details/Epanutin-phenytoin-30mg5ml-oral-suspension-supply-disruption?utm_source=Royal%20Pharmaceutical%20Society&utm_medium=email&utm_campaign=10619610_Medicine%20supply%20issue&dm_i=EQ,6BM56,JNZO7,OZ7AG,1

Please see the information below from NHS England about impending medicines shortages.   Dear Colleague, We would like to inform...